Nashua, NH – The International Society of Pharmaceutical Engineering (ISPE) has announced that CRISPR Therapeutics’ new manufacturing facility in Framingham, Mass. was awarded a Facility of the Year Award (FOYA) for Innovation based on the design of the facility, which provides an end-to-end solution for production and fills operations.
DECCO, Inc. served as process piping contractor for the 55,000sf interior fit-out of existing shell space for the new cGMP biologics manufacturing facility, including lab spaces, MST labs, warehouse, utilities, and office space.
“DECCO was pleased to work with the team at CRISPR, DPS, TRIA Design
and Commodore Builders to bring this project to fruition,” notes Kyle Reagan,
CEO, DECCO, Inc. “We collaborated with this project team to understand
the mission of this unique project, overcome challenges, and provide quality craft professionals to support process piping services. Congratulations on a stellar project.”
FOYA is a global awards program recognizing innovation and creativity in manufacturing facilities serving the regulated healthcare industry. The award-winning projects selected by the FOYA program demonstrate excellence in facility design, construction, and operations.
